Literature DB >> 11599592

Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.

M L Smith1, E T Shimomura, J Summers, B D Paul, A J Jenkins, W D Darwin, E J Cone.   

Abstract

Heroin is one of the major target drugs in workplace drug-testing programs because of its history of abuse, liability, and continued negative social impact. This study was a comprehensive examination of pharmacokinetics, pharmacodynamics, detection times, opiate immunoassay performance, and urine excretion profiles following single doses of heroin administered to human subjects via smoking and intravenous routes. Studies of the first four components of this investigation were previously published. This article describes the urine excretion profiles. Total morphine (Tmor), free morphine (Fmor), and 6-acetylmorphine (6-AM) were measured by gas chromatography-mass spectrometry (GC-MS) in 920 urine samples collected from 11 male human subjects following single doses of heroin. Eight received intravenous doses of 3, 6, and 12 mg heroin HCI and four smoked 3.5-, 5.2-, 7-, 10.5-, or 13.9-mg doses of heroin (base). In addition, 183 urine-based blind quality-control samples were added to the study set to assess assay performance. Creatinine was also measured in each sample by a colorimetric technique. The parameters studied were not significantly dependent on route of administration. Excretion half-life mean +/- SD for Tmor was 3.11 +/- 0.30 h. Range (median) of peak urine concentrations, time to peak, time to last positive sample for low cutoff (300 ng/mL) and high cutoff (2000 ng/mL) for Tmor following lower doses (< or = 7 mg) were, respectively, 1392-9250 (3620) ng/mL, 1.2-6.2 (2.3) h, 7.4-31.9 (7.4) h, and 0-10.1 (4.3) h. Following higher doses (> 10 mg) they were 2065-29,030 (16,470) ng/mL, 2.3-9.3 (4.5) h, 10.7-53.5 (34.4) h, 2.3-22.3 (8.3) h. Fmor peaked in the same sample as Tmor. Range (median) of peak Fmor concentrations and time to last positive using a cutoff of 100 ng/mL for low and high doses were, respectively, 117-1160 (415) ng/mL, 1.2-10.1 (4.5) h and 150-2580 (1400) ng/mL, 2.3-29.1 (9.3) h. The range (median) of peak urine concentrations for 6-AM was 6.1-568 (124) ng/mL. In general, the first urine void had the peak 6-AM concentration and was the only specimen positive at a 10-ng/mL cutoff. As previously reported urine concentrations varied greatly between subjects and within subjects with time after dosing but were much more predictable when values were reported as amount of drug per unit of creatinine. The range (median) values for percent of heroin excreted into urine as Tmor was 12.8-88.5% (51.0).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599592     DOI: 10.1093/jat/25.7.504

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  7 in total

Review 1.  Laboratory testing for prescription opioids.

Authors:  Michael C Milone
Journal:  J Med Toxicol       Date:  2012-12

2.  Toxicologic testing for opiates: understanding false-positive and false-negative test results.

Authors:  Christopher J Keary; Ying Wang; Jonathan R Moran; Lazaro V Zayas; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2012-07-26

3.  A comparison of opioid-involved fatalities captured in the National Poison Data System to data derived from US death certificate literal text.

Authors:  Celeste A Mallama; James P Trinidad; Richard S Swain; Yueqin Zhao; Corinne Woods; Jana K McAninch
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-08-11       Impact factor: 2.890

4.  Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content.

Authors:  Michael L Smith; Daniel C Nichols; Paula Underwood; Zachary Fuller; Matthew A Moser; Charles LoDico; David A Gorelick; Matthew N Newmeyer; Marta Concheiro; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2014-05-14       Impact factor: 2.395

5.  Relapse of polymicrobial endocarditis in an intravenous drug user.

Authors:  Ruth W Wang'ondu; Thomas S Murray
Journal:  Yale J Biol Med       Date:  2011-09

6.  Heroin-Related Compounds and Metabolic Ratios in Postmortem Samples Using LC-MS-MS.

Authors:  Gerd Jakobsson; Michael T Truver; Sonja A Wrobel; Henrik Gréen; Robert Kronstrand
Journal:  J Anal Toxicol       Date:  2021-03-12       Impact factor: 3.367

7.  Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.

Authors:  Matthew D Krasowski; Anthony F Pizon; Mohamed G Siam; Spiros Giannoutsos; Manisha Iyer; Sean Ekins
Journal:  BMC Emerg Med       Date:  2009-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.